Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 213951
Company: VISTAPHARM

Products on ANDA 213951

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ACYCLOVIR	ACYCLOVIR	200MG/5ML	SUSPENSION;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 213951

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/11/2021	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 213951

ACYCLOVIR

SUSPENSION;ORAL; 200MG/5ML
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ACYCLOVIR	ACYCLOVIR	200MG/5ML	SUSPENSION;ORAL	Prescription	No	AB	074738	ACTAVIS MID ATLANTIC
ACYCLOVIR	ACYCLOVIR	200MG/5ML	SUSPENSION;ORAL	Prescription	No	AB	077026	AKORN
ACYCLOVIR	ACYCLOVIR	200MG/5ML	SUSPENSION;ORAL	Prescription	No	AB	212718	CHARTWELL RX
ACYCLOVIR	ACYCLOVIR	200MG/5ML	SUSPENSION;ORAL	Prescription	No	AB	215669	HETERO LABS LTD III
ACYCLOVIR	ACYCLOVIR	200MG/5ML	SUSPENSION;ORAL	Prescription	No	AB	217393	MSN
ACYCLOVIR	ACYCLOVIR	200MG/5ML	SUSPENSION;ORAL	Prescription	No	AB	212252	NOVITIUM PHARMA
ACYCLOVIR	ACYCLOVIR	200MG/5ML	SUSPENSION;ORAL	Prescription	No	AB	215724	RUBICON
ACYCLOVIR	ACYCLOVIR	200MG/5ML	SUSPENSION;ORAL	Prescription	No	AB	213951	VISTAPHARM